Found: 6
Select item for more details and to access through your institution.
An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.
- Published in:
- Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa029
- By:
- Publication type:
- Article
Optimal regimens of sulfamethoxazoletrimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-016-1206-8
- By:
- Publication type:
- Article
Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 4, p. 752, doi. 10.3109/s10165-012-0730-x
- By:
- Publication type:
- Article
A case of IgG4-related disease with features of Mikulicz's disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman's disease.
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 4, p. 410, doi. 10.3109/s10165-010-0410-7
- By:
- Publication type:
- Article
Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 5, p. 981, doi. 10.1002/ccr3.2139
- By:
- Publication type:
- Article